ITMI20052037A1 - Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato - Google Patents

Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato

Info

Publication number: ITMI20052037A1
Authority: IT; Italy
Prior art keywords: amino acids; pharmaceutical compositions; chicatrizers; sodium hyaluronate; under
Prior art date: 2005-10-26

Application number

IT002037A

Other languages

English (en)

Inventor

Franco Conti

Original Assignee

Professional Dietetics Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-26

Filing date

2005-10-26

Publication date

2007-04-27

2005-10-26 Application filed by Professional Dietetics Srl filed Critical Professional Dietetics Srl

2005-10-26 Priority to IT002037A priority Critical patent/ITMI20052037A1/it

2006-09-16 Priority to US12/091,551 priority patent/US20080261915A1/en

2006-10-16 Priority to DE602006020155T priority patent/DE602006020155D1/de

2006-10-16 Priority to EP06806305A priority patent/EP1940478B1/en

2006-10-16 Priority to ES06806305T priority patent/ES2357415T3/es

2006-10-16 Priority to AT06806305T priority patent/ATE498413T1/de

2006-10-16 Priority to PCT/EP2006/009968 priority patent/WO2007048524A2/en

2006-10-16 Priority to KR1020087009862A priority patent/KR101367340B1/ko

2006-10-16 Priority to PT06806305T priority patent/PT1940478E/pt

2006-10-16 Priority to JP2008536975A priority patent/JP5334584B2/ja

2006-10-16 Priority to CA2627223A priority patent/CA2627223C/en

2007-04-27 Publication of ITMI20052037A1 publication Critical patent/ITMI20052037A1/it

2010-12-09 Priority to US12/964,419 priority patent/US8426384B2/en

Links

229920002385 Sodium hyaluronate Polymers 0.000 title abstract 2
150000001413 amino acids Chemical class 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000000843 powder Substances 0.000 title abstract 2
229940010747 sodium hyaluronate Drugs 0.000 title abstract 2
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title abstract 2
230000029663 wound healing Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
- A61L2300/214—Amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Materials Engineering (AREA)
Hematology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

IT002037A 2005-10-26 2005-10-26 Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato ITMI20052037A1 (it)

Priority Applications (12)

Application Number	Priority Date	Filing Date	Title
IT002037A ITMI20052037A1 (it)	2005-10-26	2005-10-26	Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato
US12/091,551 US20080261915A1 (en)	2005-10-26	2006-09-16	Wound-Healing Pharmaceutical Compositions in the Form of a Sterile Powder Based on Amino Acids and Sodium Hyaluronate
AT06806305T ATE498413T1 (de)	2005-10-26	2006-10-16	Pharmazeutische wundheilungs-zusammensetzungen in form eines sterilen pulvers auf basis von aminosäuren und natriumhyaluronat
EP06806305A EP1940478B1 (en)	2005-10-26	2006-10-16	Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate
ES06806305T ES2357415T3 (es)	2005-10-26	2006-10-16	Composiciones farmacéuticas para la cicatrización de heridas en forma de un polvo estéril a base de aminoácidos y hialuronato de sodio.
DE602006020155T DE602006020155D1 (de)	2005-10-26	2006-10-16	Pharmazeutische wundheilungs-zusammensetzungen in ren und natriumhyaluronat
PCT/EP2006/009968 WO2007048524A2 (en)	2005-10-26	2006-10-16	Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate
KR1020087009862A KR101367340B1 (ko)	2005-10-26	2006-10-16	아미노산 및 히알루론산 나트륨에 기반한 멸균 분말 제형의상처-치료용 약학적 조성물
PT06806305T PT1940478E (pt)	2005-10-26	2006-10-16	Composições farmacêuticas para a cicatrização de feridas na forma de um pó estéril à base de aminoácidos e hialuronato de sódio
JP2008536975A JP5334584B2 (ja)	2005-10-26	2006-10-16	アミノ酸とヒアルロン酸ナトリウムを基にした滅菌粉末の形態の創傷治癒医薬組成物
CA2627223A CA2627223C (en)	2005-10-26	2006-10-16	Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate
US12/964,419 US8426384B2 (en)	2005-10-26	2010-12-09	Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT002037A ITMI20052037A1 (it)	2005-10-26	2005-10-26	Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato

Publications (1)

Publication Number	Publication Date
ITMI20052037A1 true ITMI20052037A1 (it)	2007-04-27

Family

ID=37903460

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT002037A ITMI20052037A1 (it)	2005-10-26	2005-10-26	Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato

Country Status (11)

Country	Link
US (2)	US20080261915A1 (it)
EP (1)	EP1940478B1 (it)
JP (1)	JP5334584B2 (it)
KR (1)	KR101367340B1 (it)
AT (1)	ATE498413T1 (it)
CA (1)	CA2627223C (it)
DE (1)	DE602006020155D1 (it)
ES (1)	ES2357415T3 (it)
IT (1)	ITMI20052037A1 (it)
PT (1)	PT1940478E (it)
WO (1)	WO2007048524A2 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20052037A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato
ITMI20052036A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato
ITMI20052035A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
IT1396935B1 (it) *	2009-11-26	2012-12-20	Solartium Entpr Ltd	Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
IT1397522B1 (it) *	2009-12-21	2013-01-16	Solartium Entpr Ltd	Uso di una combinazione per il trattamento dell'osteoartrosi
ITMI20110954A1 (it) *	2011-05-26	2012-11-27	Professional Dietetics Srl	Combinazioni per il trattamento delle mucositi vaginali o rettali
CN111748071B (zh) *	2020-06-29	2022-03-01	武汉瑞法医疗器械有限公司	一种亲水性聚氨酯泡沫敷料及其制备方法
WO2025196725A1 (en) *	2024-03-22	2025-09-25	The Wave Innovation Group S.R.L.	Patent application for the industrial invention entitled: a composition based on hyaluronic acid and amino acids for use in the treatment of periodontal wounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1165243A (en) *	1980-02-19	1984-04-10	Anthony N. Silvetti	Method and composition for treatment of wounds
US4707354A (en) *	1985-06-17	1987-11-17	Alpen Tau, Inc.	Mature skin treatment and protectant compositions and methods of using same
AU3070395A (en) *	1994-07-22	1996-02-22	Alcon Laboratories, Inc.	Use of low molecular weight amino acids in ophthalmic compositions
US6541460B2 (en) *	1996-08-07	2003-04-01	George D. Petito	Method for use of hyaluronic acid in wound management
US6645948B2 (en) *	1998-03-24	2003-11-11	George D. Petito	Nutritional composition for the treatment of connective tissue
IT1318556B1 (it) *	2000-06-07	2003-08-27	Solartium Establishment	Composizione farmaceutica a base di prolina, glicina e lisina utilenella terapia per la cicatrizzazione delle ferite e delle lesioni
FR2820635B1 (fr) *	2001-02-09	2005-01-21	Genevrier Lab	Procede de preparation d'une creme a base d'acide hyaluronique
ITTO20010804A1 (it) *	2001-08-08	2003-02-08	Professional Dietetics Srl	Composizioni a base di aminoacidi, idonee alla terapia per la cicatrizzazione e/o riparazione di ferite e lesioni, in particolare per l'appl
US20040265268A1 (en) *	2001-08-18	2004-12-30	Deepak Jain	Compositions and methods for skin rejuvenation and repair
US6780841B2 (en) *	2001-11-13	2004-08-24	Biocell Technology, Llc	Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
US20040180025A1 (en) *	2003-03-12	2004-09-16	New Life Resources, Llc	Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
FR2864445B1 (fr) *	2003-12-30	2006-04-28	Jean Noel Thorel	Utilisation topique d'une base nutritive complexe
ITMI20052036A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato
ITMI20052035A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
ITMI20052037A1 (it)	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato

2005
- 2005-10-26 IT IT002037A patent/ITMI20052037A1/it unknown
2006
- 2006-09-16 US US12/091,551 patent/US20080261915A1/en not_active Abandoned
- 2006-10-16 EP EP06806305A patent/EP1940478B1/en not_active Not-in-force
- 2006-10-16 JP JP2008536975A patent/JP5334584B2/ja not_active Expired - Fee Related
- 2006-10-16 AT AT06806305T patent/ATE498413T1/de active
- 2006-10-16 PT PT06806305T patent/PT1940478E/pt unknown
- 2006-10-16 KR KR1020087009862A patent/KR101367340B1/ko not_active Expired - Fee Related
- 2006-10-16 WO PCT/EP2006/009968 patent/WO2007048524A2/en not_active Ceased
- 2006-10-16 CA CA2627223A patent/CA2627223C/en not_active Expired - Fee Related
- 2006-10-16 DE DE602006020155T patent/DE602006020155D1/de active Active
- 2006-10-16 ES ES06806305T patent/ES2357415T3/es active Active
2010
- 2010-12-09 US US12/964,419 patent/US8426384B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20110077218A1 (en)	2011-03-31
DE602006020155D1 (de)	2011-03-31
EP1940478B1 (en)	2011-02-16
ATE498413T1 (de)	2011-03-15
JP5334584B2 (ja)	2013-11-06
KR101367340B1 (ko)	2014-02-28
ES2357415T3 (es)	2011-04-26
WO2007048524A2 (en)	2007-05-03
CA2627223A1 (en)	2007-05-03
CA2627223C (en)	2014-04-08
US20080261915A1 (en)	2008-10-23
KR20080065982A (ko)	2008-07-15
WO2007048524A3 (en)	2008-01-31
EP1940478A2 (en)	2008-07-09
PT1940478E (pt)	2011-03-07
US8426384B2 (en)	2013-04-23
JP2009513587A (ja)	2009-04-02

Publication	Publication Date	Title
ITMI20052036A1 (it)	2007-04-27	Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato
ITMI20052035A1 (it)	2007-04-27	Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
BR112012011332A2 (pt)	2016-11-22	agentes direcionados para gadd45beta
CY1118038T1 (el)	2017-05-17	Λυοφιλισμενες φαρμακοτεχνικες μορφες θεραπευτικου πεπτισωματος
CY1113003T1 (el)	2016-04-13	Ευσταθη παρασκευασματα laquinimod
BRPI0815395A2 (pt)	2015-02-10	Composição, vetor, produto, formulação farmacêutica, me´todo in vitro para determinar se as células t reconhecem um polipeptídeo, e, método in vitro para determinar se um indivíduo se encontra ou está em risco de uma condição.
ECSP077238A (es)	2007-04-26	Composiciones para entrega de drogas altamente solubles en agua
ATE404225T1 (de)	2008-08-15	Radiofluorierte peptide
MX2009008925A (es)	2009-08-28	Compuestos de la formula (i) como inhibidores de proteasa de serina.
TR200401793T4 (tr)	2004-08-23	Perindopril tuzu ve bunu içeren farmasötik bileşimler.
BRPI0606687A2 (pt)	2009-07-14	composições nutracêuticas
MX2009012536A (es)	2009-12-03	Una composicion de liberacion prolongada que comprende un derivado de somatostatina en microparticulas.
ITMI20052037A1 (it)	2007-04-27	Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato
BRPI0417950A (pt)	2007-04-17	composições farmacêuticas
BRPI0707420A8 (pt)	2019-01-15	composições contendo peptídeos com aminoácidos e métodos não naturais do uso
CL2004000535A1 (es)	2005-01-14	Composicion farmaceutica que comprende rapamicina o un derivado de rapamicina y pimecrolimus; y su uso para el tratamiento de enfermedad inflamatoria del intestino.
ZA200804163B (en)	2009-10-28	New adjuvants on the basis of bisacyloxypropylcysteine conjugates and derivatives and their uses in pharmaceutical compositions
CY1112134T1 (el)	2015-11-04	Φαρμακευτικες συνθεσεις που περιεχουν ανταγωνιστες βραδυκινινης και υαλουρονικο οξυ και χρησεις αυτων
BRPI0417205A (pt)	2007-02-06	composições farmacêuticas
IL191992A0 (en)	2008-12-29	Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
ATE450273T1 (de)	2009-12-15	Proliferationshemmendes arzneimittel
BRPI0411820A (pt)	2006-08-08	composição farmacêutica
DE602006008023D1 (de)	2009-09-03	Hexoxylceramide als adjuvantien und ihre verwendungen in pharmazeutischen zusammensetzungen
UA87692C2 (ru)	2009-08-10	Фармацевтическая композиция, содержащая рисперидон и распадающаяся при пероральном приеме
UY27628A1 (es)	2003-08-29	"2'-halo -3',5'-dialcoxi-fen-1'il-2-imidazolidinas y su uso como un fármaco"